Skip to main content

What the FDA labels say about taking them together

Anagrelide and pimozide

Anagrelide's FDA label of April 8, 2026 names pimozide in its drug interactions section; the pimozide label PlainMeds reads does not name anagrelide. The anagrelide label: “Drugs that Prolong QT Avoid use of AGRYLIN in patients taking medications that may prolong QT interval.”

Check it at the source: the anagrelide FDA label on DailyMed (effective April 8, 2026, Takeda Pharmaceuticals America, Inc.); the pimozide FDA label on DailyMed (effective August 12, 2026, Par Health USA, LLC).

What does the anagrelide label say about pimozide?

Anagrelide label, drug interactions

Drugs that Prolong QT Avoid use of AGRYLIN in patients taking medications that may prolong QT interval (including, but not limited to, chloroquine, clarithromycin, haloperidol, methadone, moxifloxacin, amiodarone, disopyramide, procainamide, and pimozide) [see Warnings and Precautions (5.1) and Clinical Pharmacology (12.2) ].

Source: FDA drug label (Agrylin), Takeda Pharmaceuticals America, Inc., effective April 8, 2026 (SPL set cb960074-99c1-4a73-941f-f0644a7ec219), via openFDA; the full label on DailyMed

What does the pimozide label say about anagrelide?

Pimozide's label (effective August 12, 2026) does not name anagrelide in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Pimozide), Par Health USA, LLC, effective August 12, 2026 (SPL set 70b079e2-a1f7-4a93-8685-d60a4d7c1280), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

3Anagrelide generic labelers
2Pimozide generic labelers
AnagrelidePimozide
Labeled forn/an/a
Boxed warningNoNo
Pharmacy cost (NADAC)$0.729 per capsule 0.5 mg capsule$1.23 per tablet 1 mg tablet
Shortage nowA presentation being discontinuedNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?